Traws Pharma, Inc.
General ticker "TRAW" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $17.0M (TTM average)
Traws Pharma, Inc. does not follow the US Stock Market performance with the rate: -2.7%.
Estimated limits based on current volatility of 20.6%: low 1.21$, high 1.84$
Factors to consider:
- Total employees count: 64 as of 2013
Short-term TRAW quotes
Long-term TRAW plot
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.23MM | $0.23MM | $0.23MM |
| Operating Expenses | $19.85MM | $20.52MM | $49.57MM |
| Operating Income | $-19.63MM | $-20.30MM | $-49.35MM |
| Non-Operating Income | $0.66MM | $1.35MM | $-117.17MM |
| R&D Expense | $11.41MM | $11.43MM | $130.31MM |
| Income(Loss) | $-18.96MM | $-18.95MM | $-166.52MM |
| Profit(Loss)* | $-18.96MM | $-18.95MM | $-54.67MM |
| Stockholders Equity | $28.31MM | $10.67MM | $-31.63MM |
| Assets | $39.37MM | $22.68MM | $24.96MM |
| Operating Cash Flow | $-16.29MM | $-17.93MM | $-29.79MM |
| Capital expenditure | $0.00MM | $0.01MM | $0.00MM |
| Investing Cash Flow | $0.00MM | $-0.01MM | $-3.65MM |
| Financing Cash Flow | $0.00MM | $0.00MM | $33.98MM |
| Earnings Per Share** | $-22.68 | $-22.57 | $-35.21 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.